Delineating the cytogenomic and epigenomic landscapes of glioma stem cell lines.

Glioblastoma multiforme (GBM), the most common and malignant type of glioma, is characterized by a poor prognosis and the lack of an effective treatment, which are due to a small sub-population of cells with stem-like properties, termed glioma stem cells (GSCs). The term "multiforme" descr...

Full description

Bibliographic Details
Main Authors: Simona Baronchelli, Angela Bentivegna, Serena Redaelli, Gabriele Riva, Valentina Butta, Laura Paoletta, Giuseppe Isimbaldi, Monica Miozzo, Silvia Tabano, Antonio Daga, Daniela Marubbi, Monica Cattaneo, Ida Biunno, Leda Dalprà
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3585345?pdf=render
_version_ 1828401765598363648
author Simona Baronchelli
Angela Bentivegna
Serena Redaelli
Gabriele Riva
Valentina Butta
Laura Paoletta
Giuseppe Isimbaldi
Monica Miozzo
Silvia Tabano
Antonio Daga
Daniela Marubbi
Monica Cattaneo
Ida Biunno
Leda Dalprà
author_facet Simona Baronchelli
Angela Bentivegna
Serena Redaelli
Gabriele Riva
Valentina Butta
Laura Paoletta
Giuseppe Isimbaldi
Monica Miozzo
Silvia Tabano
Antonio Daga
Daniela Marubbi
Monica Cattaneo
Ida Biunno
Leda Dalprà
author_sort Simona Baronchelli
collection DOAJ
description Glioblastoma multiforme (GBM), the most common and malignant type of glioma, is characterized by a poor prognosis and the lack of an effective treatment, which are due to a small sub-population of cells with stem-like properties, termed glioma stem cells (GSCs). The term "multiforme" describes the histological features of this tumor, that is, the cellular and morphological heterogeneity. At the molecular level multiple layers of alterations may reflect this heterogeneity providing together the driving force for tumor initiation and development. In order to decipher the common "signature" of the ancestral GSC population, we examined six already characterized GSC lines evaluating their cytogenomic and epigenomic profiles through a multilevel approach (conventional cytogenetic, FISH, aCGH, MeDIP-Chip and functional bioinformatic analysis). We found several canonical cytogenetic alterations associated with GBM and a common minimal deleted region (MDR) at 1p36.31, including CAMTA1 gene, a putative tumor suppressor gene, specific for the GSC population. Therefore, on one hand our data confirm a role of driver mutations for copy number alterations (CNAs) included in the GBM genomic-signature (gain of chromosome 7- EGFR gene, loss of chromosome 13- RB1 gene, loss of chromosome 10-PTEN gene); on the other, it is not obvious that the new identified CNAs are passenger mutations, as they may be necessary for tumor progression specific for the individual patient. Through our approach, we were able to demonstrate that not only individual genes into a pathway can be perturbed through multiple mechanisms and at different levels, but also that different combinations of perturbed genes can incapacitate functional modules within a cellular networks. Therefore, beyond the differences that can create apparent heterogeneity of alterations among GSC lines, there's a sort of selective force acting on them in order to converge towards the impairment of cell development and differentiation processes. This new overview could have a huge importance in therapy.
first_indexed 2024-12-10T09:51:25Z
format Article
id doaj.art-2a574df177324bcab0ceb70c67268253
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-10T09:51:25Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-2a574df177324bcab0ceb70c672682532022-12-22T01:53:40ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0182e5746210.1371/journal.pone.0057462Delineating the cytogenomic and epigenomic landscapes of glioma stem cell lines.Simona BaronchelliAngela BentivegnaSerena RedaelliGabriele RivaValentina ButtaLaura PaolettaGiuseppe IsimbaldiMonica MiozzoSilvia TabanoAntonio DagaDaniela MarubbiMonica CattaneoIda BiunnoLeda DalpràGlioblastoma multiforme (GBM), the most common and malignant type of glioma, is characterized by a poor prognosis and the lack of an effective treatment, which are due to a small sub-population of cells with stem-like properties, termed glioma stem cells (GSCs). The term "multiforme" describes the histological features of this tumor, that is, the cellular and morphological heterogeneity. At the molecular level multiple layers of alterations may reflect this heterogeneity providing together the driving force for tumor initiation and development. In order to decipher the common "signature" of the ancestral GSC population, we examined six already characterized GSC lines evaluating their cytogenomic and epigenomic profiles through a multilevel approach (conventional cytogenetic, FISH, aCGH, MeDIP-Chip and functional bioinformatic analysis). We found several canonical cytogenetic alterations associated with GBM and a common minimal deleted region (MDR) at 1p36.31, including CAMTA1 gene, a putative tumor suppressor gene, specific for the GSC population. Therefore, on one hand our data confirm a role of driver mutations for copy number alterations (CNAs) included in the GBM genomic-signature (gain of chromosome 7- EGFR gene, loss of chromosome 13- RB1 gene, loss of chromosome 10-PTEN gene); on the other, it is not obvious that the new identified CNAs are passenger mutations, as they may be necessary for tumor progression specific for the individual patient. Through our approach, we were able to demonstrate that not only individual genes into a pathway can be perturbed through multiple mechanisms and at different levels, but also that different combinations of perturbed genes can incapacitate functional modules within a cellular networks. Therefore, beyond the differences that can create apparent heterogeneity of alterations among GSC lines, there's a sort of selective force acting on them in order to converge towards the impairment of cell development and differentiation processes. This new overview could have a huge importance in therapy.http://europepmc.org/articles/PMC3585345?pdf=render
spellingShingle Simona Baronchelli
Angela Bentivegna
Serena Redaelli
Gabriele Riva
Valentina Butta
Laura Paoletta
Giuseppe Isimbaldi
Monica Miozzo
Silvia Tabano
Antonio Daga
Daniela Marubbi
Monica Cattaneo
Ida Biunno
Leda Dalprà
Delineating the cytogenomic and epigenomic landscapes of glioma stem cell lines.
PLoS ONE
title Delineating the cytogenomic and epigenomic landscapes of glioma stem cell lines.
title_full Delineating the cytogenomic and epigenomic landscapes of glioma stem cell lines.
title_fullStr Delineating the cytogenomic and epigenomic landscapes of glioma stem cell lines.
title_full_unstemmed Delineating the cytogenomic and epigenomic landscapes of glioma stem cell lines.
title_short Delineating the cytogenomic and epigenomic landscapes of glioma stem cell lines.
title_sort delineating the cytogenomic and epigenomic landscapes of glioma stem cell lines
url http://europepmc.org/articles/PMC3585345?pdf=render
work_keys_str_mv AT simonabaronchelli delineatingthecytogenomicandepigenomiclandscapesofgliomastemcelllines
AT angelabentivegna delineatingthecytogenomicandepigenomiclandscapesofgliomastemcelllines
AT serenaredaelli delineatingthecytogenomicandepigenomiclandscapesofgliomastemcelllines
AT gabrieleriva delineatingthecytogenomicandepigenomiclandscapesofgliomastemcelllines
AT valentinabutta delineatingthecytogenomicandepigenomiclandscapesofgliomastemcelllines
AT laurapaoletta delineatingthecytogenomicandepigenomiclandscapesofgliomastemcelllines
AT giuseppeisimbaldi delineatingthecytogenomicandepigenomiclandscapesofgliomastemcelllines
AT monicamiozzo delineatingthecytogenomicandepigenomiclandscapesofgliomastemcelllines
AT silviatabano delineatingthecytogenomicandepigenomiclandscapesofgliomastemcelllines
AT antoniodaga delineatingthecytogenomicandepigenomiclandscapesofgliomastemcelllines
AT danielamarubbi delineatingthecytogenomicandepigenomiclandscapesofgliomastemcelllines
AT monicacattaneo delineatingthecytogenomicandepigenomiclandscapesofgliomastemcelllines
AT idabiunno delineatingthecytogenomicandepigenomiclandscapesofgliomastemcelllines
AT ledadalpra delineatingthecytogenomicandepigenomiclandscapesofgliomastemcelllines